In the research paper entitled "Efficacy and Safety of Anti-calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies in Preventing Migraine: A Systematic Review," a group of dedicated authors collaborated to investigate the effectiveness of CGRP monoclonal antibodies in migraine prevention. Here, CALCA is linked to migraine disorder.